Matthew Hand, PA
Physician Assistant · Oklahoma City
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
- Since medical school
- 26 years
- Graduated 2000
Offices
1 location · Cardiovascular Health Clinic PLLC · 23 clinicians in this group
Looking this up.
Hospitals listed: Oklahoma Heart Hospital, LLC. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Matthew Hand’s office at (405) 241-3539 to ask if they take your plan before you enroll.
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Oklahoma Heart Hospital, LLCOklahoma City, OKAcute Care Hospital · Physician · Has an emergency departmentPatients rate it 5 of 5 · 91% would definitely recommend itOverall rating: 4 of 5 starsWorse than the national rate — Postoperative hemorrhage or hematoma rate: 3.83 (2.74 to 4.92) · 2,823 cases, Jul 2022 – Jun 2024Better than the national rate — Clostridium Difficile (C.Diff): 0, Oct 2024 – Sep 2025
See every measure and the patient survey for Oklahoma Heart Hospital, LLC
Behind the star rating — Deaths: 0 better, 6 the same, 1 worse of 7 measures. Safety: 1 better, 3 the same, 0 worse of 4 measures. Readmissions: 0 better, 5 the same, 2 worse of 7 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Postoperative hemorrhage or hematoma rateComplications and deaths | 3.83 (2.74 to 4.92) · 2,823 cases | Worse | Jul 2022 – Jun 2024 |
| Clostridium Difficile (C.Diff)Infections | 0 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1 (0 to 2.06) · 275 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.96 (0.67 to 1.24) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 169.56 (125.38 to 213.74) · 149 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 1.5 · 805 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.5 · 670 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 13.5 · 827 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 18.1 · 107 cases | None | Jul 2022 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 5 · 2,218 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.21 (0.03 to 0.4) · 3,719 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.26 (0.06 to 0.46) · 5,251 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.11 (1.13 to 5.08) · 2,927 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.4 (0.32 to 2.48) · 1,523 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 8.58 (5.17 to 11.99) · 1,440 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.56 (1.48 to 7.64) · 1,535 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.73 (0.21 to 3.24) · 45 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.68 (0 to 1.44) · 3,147 cases | No different | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.243 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.927 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14 · 962 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.3 · 870 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -2.1 · 858 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -4.5 · 930 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 16.8 · 119 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.4 · 96 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 10.6 · 737 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.8 · 28 cases | None | Jul 2023 – Jun 2025 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1.2 (0.9 to 1.6) · 276 cases | No different | Jan 2024 – Dec 2024 |
What patients said (1,244 patients answered, 36% of those asked)
| Cleanliness | 5 |
| Nurse communication | 5 |
| Doctor communication | 5 |
| Communication about medicines | 4 |
| Discharge information | 4 |
| Overall hospital rating | 5 |
| Quietness | 5 |
| Recommend hospital | 5 |
| Room was "always" clean | 84% |
| Nurses "always" communicated well | 87% |
| Doctors "always" communicated well | 89% |
| Staff "always" explained | 69% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 87% |
| Doctors "always" explained things so they could understand | 85% |
| Doctors "always" listened carefully | 88% |
| Doctors "always" treated them with courtesy and respect | 92% |
| Patients who gave a rating of "9" or "10" (high) | 90% |
| Staff "always" explained new medications | 81% |
| Nurses "always" explained things so they could understand | 82% |
| Nurses "always" listened carefully | 87% |
| Nurses "always" treated them with courtesy and respect | 92% |
| "Always" quiet at night | 79% |
| "YES", patients would definitely recommend the hospital | 91% |
| Staff "always" explained possible side effects | 58% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
Original Medicare doctor bills
$86,943
Medicare paid this office $86,943 for 1,055 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Short return visit (20+ min) | 718 | $42,968 | $51 |
| Return visit (30+ min) | 361 | $28,396 | $71 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 747 | $6,892 | $8 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 406 | $4,420 | $10 |
| Short return visit | 63 | $2,276 | $35 |
See all 6 services
| Short return visit (20+ min) | 718 | $42,968 | $51 |
| Return visit (30+ min) | 361 | $28,396 | $71 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 747 | $6,892 | $8 |
| Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | 406 | $4,420 | $10 |
| Short return visit | 63 | $2,276 | $35 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 11 | $798 | $50 |
Who their Medicare patients are
1,055 Original Medicare patients in 2024. Average age 77 · Under 65 2% · 85 and older 16% · Women 47% · Also on Medicaid 3% · Health risk score 1.22. At or below the middle of the specialty; the typical physician assistant clinician is at 1.31.
Conditions among them: High blood pressure 75% · Coronary heart disease 67% · Atrial fibrillation 44% · Diabetes 32% · Chronic kidney disease 25% · Heart failure 19% · COPD 19% · Depression 16% · Cancer 14% · Stroke 8% · Dementia 6%.
The office billed $447,816, Medicare allowed $119,909 and paid $86,943; for 2,686 services of 11 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 1,055 | 2,686 | 77 | 1.22 | $447,816 | $86,943 |
| 2023 | 1,024 | 2,187 | 77 | 1.25 | $405,767 | $77,013 |
| 2022 | 921 | 1,918 | 76 | 1.23 | $373,261 | $71,489 |
| 2021 | 951 | 1,861 | 76 | 1.22 | $347,563 | $80,075 |
| 2020 | 922 | 1,535 | 76 | 1.24 | $238,047 | $53,431 |
| 2019 | 973 | 1,632 | 76 | 1.30 | $271,809 | $63,855 |
| 2018 | 824 | 1,355 | 76 | 1.32 | $221,594 | $48,843 |
| 2017 | 741 | 1,147 | 76 | 1.34 | $204,364 | $45,678 |
| 2016 | 210 | 266 | 76 | 1.24 | $49,429 | $11,790 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 5 services
| Short return visit (20+ min) | 895 | $54,908 | $49 |
| Return visit (30+ min) | 138 | $11,521 | $78 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 698 | $6,480 | $8 |
| Short return visit | 51 | $1,552 | $30 |
| New patient visit (30+ min) | 16 | $1,057 | $66 |
2022: 5 services
| Short return visit (20+ min) | 830 | $56,979 | $50 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 465 | $4,779 | $8 |
| Return visit (30+ min) | 53 | $3,064 | $57 |
| Short return visit | 75 | $2,494 | $32 |
| New patient visit (30+ min) | 29 | $1,986 | $68 |
2021: 6 services
| Short return visit (20+ min) | 785 | $52,130 | $50 |
| Return visit (30+ min) | 231 | $20,331 | $78 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 399 | $3,588 | $7 |
| New patient visit (45+ min) | 15 | $1,520 | $101 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 11 | $852 | $47 |
| Short return visit | 16 | $582 | $36 |
2020: 5 services
| Short return visit (20+ min) | 814 | $41,075 | $42 |
| Return visit (30+ min) | 65 | $4,533 | $68 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 336 | $3,435 | $9 |
| New patient visit (45+ min) | 26 | $2,253 | $87 |
| Office for the evaluation and management of established patient that may not require presence of healthcare professional | 34 | $473 | $14 |
2019: 5 services
| Short return visit (20+ min) | 880 | $49,813 | $43 |
| Return visit (30+ min) | 82 | $5,903 | $69 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 288 | $3,069 | $10 |
| New patient visit (45+ min) | 29 | $2,917 | $101 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 13 | $600 | $25 |
2018: 8 services
| Short return visit (20+ min) | 742 | $35,086 | $40 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 44 | $3,826 | $48 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 17 | $2,329 | $129 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 196 | $1,781 | $9 |
| Hospital discharge day management, 30 minutes or less | 23 | $1,146 | $48 |
| Return visit (30+ min) | 20 | $1,124 | $56 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 16 | $671 | $26 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 63 | $323 | $5 |
2017: 7 services
| Short return visit (20+ min) | 633 | $29,859 | $41 |
| Return visit (30+ min) | 106 | $6,555 | $61 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 33 | $2,772 | $47 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 18 | $1,604 | $89 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 127 | $1,295 | $10 |
| Hospital discharge day management, 30 minutes or less | 11 | $563 | $47 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 40 | $183 | $5 |
2016: 4 services
| Short return visit (20+ min) | 145 | $6,419 | $44 |
| Return visit (30+ min) | 58 | $4,058 | $67 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | 24 | $258 | $10 |
| Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | 15 | $83 | $6 |
Drugs they prescribed that Part D paid
$77,358
Pharmacies billed $77,358 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 681) in 2024. At or below the middle of the specialty; the typical physician assistant clinician is at 1%.
605 generic and 76 brand-name prescriptions · $77,358 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Eliquis | 39 | $35,959 | $922 |
| Xarelto | 16 | $14,230 | $889 |
| Flecainide Acetate | 36 | $1,935 | $54 |
| Hydralazine | 46 | $941 | $20 |
| Losartan | 38 | $916 | $24 |
See all 15 drugs
| Eliquis | 39 | $35,959 | $922 |
| Xarelto | 16 | $14,230 | $889 |
| Flecainide Acetate | 36 | $1,935 | $54 |
| Hydralazine | 46 | $941 | $20 |
| Losartan | 38 | $916 | $24 |
| Metoprolol | 75 | $795 | $11 |
| Amiodarone | 45 | $730 | $16 |
| Lisinopril | 29 | $341 | $12 |
| Atorvastatin | 22 | $315 | $14 |
| Clopidogrel | 16 | $263 | $16 |
| Metoprolol | 18 | $212 | $12 |
| Amlodipine Besylate | 31 | $189 | $6 |
| Furosemide | 25 | $124 | $5 |
| Hydrochlorothiazide | 20 | $110 | $6 |
| Spironolactone | 17 | $70 | $4 |
Year by year
| 2024 | 681 | 223 | 0% (0) | 11% | $77,358 |
| 2023 | 371 | 123 | 0% (0) | 9% | $48,232 |
| 2022 | 502 | 142 | 0% (0) | 15% | $70,106 |
| 2021 | 492 | 167 | 0% (0) | 10% | $36,071 |
| 2020 | 471 | 139 | 0% (0) | 8% | $42,112 |
| 2019 | 665 | 195 | 0% (0) | 10% | $41,813 |
| 2018 | 609 | 177 | 0% (0) | 15% | $41,409 |
| 2017 | 298 | 87 | 0% (0) | 16% | $14,858 |
| 2016 | 33 | 19 | 0% (0) | None | $563 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 8 drugs
| Eliquis | 16 | $22,878 | $1,430 |
| Hydralazine | 47 | $804 | $17 |
| Amiodarone | 29 | $713 | $25 |
| Metoprolol | 51 | $564 | $11 |
| Hydrochlorothiazide | 16 | $392 | $24 |
| Losartan | 13 | $387 | $30 |
| Lisinopril | 19 | $242 | $13 |
| Amlodipine Besylate | 12 | $140 | $12 |
2022: 15 drugs
| Eliquis | 51 | $37,696 | $739 |
| Flecainide Acetate | 15 | $1,712 | $114 |
| Losartan | 32 | $591 | $18 |
| Amiodarone | 32 | $556 | $17 |
| Hydralazine | 19 | $483 | $25 |
| Lisinopril | 49 | $437 | $9 |
| Metoprolol | 75 | $419 | $6 |
| Metoprolol | 12 | $224 | $19 |
| Clopidogrel | 12 | $210 | $18 |
| Cilostazol | 16 | $199 | $12 |
| Atorvastatin | 14 | $193 | $14 |
| Hydrochlorothiazide | 17 | $174 | $10 |
| Amlodipine Besylate | 18 | $131 | $7 |
| Atenolol | 11 | $104 | $9 |
| Simvastatin | 13 | $88 | $7 |
2021: 13 drugs
| Eliquis | 29 | $21,132 | $729 |
| Flecainide Acetate | 18 | $1,275 | $71 |
| Hydralazine | 44 | $656 | $15 |
| Losartan | 44 | $611 | $14 |
| Amiodarone | 24 | $512 | $21 |
| Isosorbide Mononitrate Er | 22 | $328 | $15 |
| Lisinopril | 34 | $274 | $8 |
| Clopidogrel | 26 | $266 | $10 |
| Metoprolol | 53 | $231 | $4 |
| Atorvastatin | 12 | $197 | $16 |
| Amlodipine Besylate | 29 | $190 | $7 |
| Cilostazol | 12 | $188 | $16 |
| Atenolol | 17 | $170 | $10 |
2020: 13 drugs
| Eliquis | 32 | $26,449 | $827 |
| Flecainide Acetate | 29 | $2,138 | $74 |
| Amiodarone | 36 | $970 | $27 |
| Bisoprolol | 20 | $822 | $41 |
| Hydralazine | 54 | $637 | $12 |
| Isosorbide Mononitrate Er | 20 | $419 | $21 |
| Metoprolol | 11 | $413 | $38 |
| Losartan | 31 | $280 | $9 |
| Torsemide | 12 | $243 | $20 |
| Metoprolol | 34 | $190 | $6 |
| Lisinopril | 23 | $138 | $6 |
| Atenolol | 21 | $125 | $6 |
| Amlodipine Besylate | 26 | $83 | $3 |
2019: 18 drugs
| Eliquis | 41 | $25,509 | $622 |
| Amiodarone | 48 | $954 | $20 |
| Flecainide Acetate | 15 | $735 | $49 |
| Hydralazine | 58 | $654 | $11 |
| Lisinopril | 63 | $478 | $8 |
| Isosorbide Mononitrate Er | 40 | $448 | $11 |
| Losartan | 34 | $360 | $11 |
| Atorvastatin | 17 | $296 | $17 |
| Metoprolol | 54 | $281 | $5 |
| Cilostazol | 11 | $223 | $20 |
| Torsemide | 21 | $217 | $10 |
| Clopidogrel | 23 | $205 | $9 |
| Hydrochlorothiazide | 31 | $181 | $6 |
| Potassium Chloride | 17 | $156 | $9 |
| Carvedilol | 13 | $115 | $9 |
| Amlodipine Besylate | 22 | $96 | $4 |
| Atenolol | 17 | $74 | $4 |
| Furosemide | 15 | $63 | $4 |
2018: 13 drugs
| Eliquis | 52 | $25,689 | $494 |
| Hydralazine | 73 | $764 | $10 |
| Isosorbide Mononitrate Er | 32 | $386 | $12 |
| Lisinopril | 62 | $347 | $6 |
| Amiodarone | 30 | $330 | $11 |
| Losartan | 40 | $246 | $6 |
| Metoprolol | 48 | $209 | $4 |
| Clopidogrel | 29 | $187 | $6 |
| Atorvastatin | 14 | $162 | $12 |
| Amlodipine Besylate | 32 | $137 | $4 |
| Terazosin | 16 | $126 | $8 |
| Atenolol | 14 | $60 | $4 |
| Carvedilol | 11 | $48 | $4 |
2017: 11 drugs
| Effient | 13 | $5,890 | $453 |
| Eliquis | 15 | $5,844 | $390 |
| Losartan | 33 | $287 | $9 |
| Isosorbide Mononitrate Er | 22 | $252 | $11 |
| Lisinopril | 40 | $220 | $5 |
| Hydralazine | 19 | $215 | $11 |
| Digoxin | 11 | $199 | $18 |
| Clopidogrel | 29 | $186 | $6 |
| Metoprolol | 25 | $106 | $4 |
| Amlodipine Besylate | 15 | $78 | $5 |
| Atorvastatin | 11 | $65 | $6 |
Money from drug and device companies
$80 in 2024
| 2024 | 4 | 5 | None | $80 |
| 2023 | 7 | 8 | None | $182 |
| 2022 | 7 | 27 | None | $676 |
| 2021 | 13 | 41 | None | $561 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| E.R. Squibb & Sons L.L.C. | Camzyos | $31 | 2 payments
|
| Bolton Medical | Treo Abdominal Stent-Graft System | $17 | 1 payment
|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Lifevest | $16 | 1 payment
|
| CVRx | Barostim Neo System | $15 | 1 payment
|
See all 5 published payments
| E.R. Squibb & Sons L.L.C. | Meals · 2024-12-05 | Camzyos | $16 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Meals · 2024-09-03 | Lifevest | $16 |
| E.R. Squibb & Sons L.L.C. | Meals · 2024-07-19 | Eliquis | $15 |
| CVRx | Meals · 2024-04-26 | Barostim Neo System | $15 |
| Bolton Medical | Meals · 2024-04-02 | Treo Abdominal Stent-Graft System | $17 |
See earlier years (2023, 2022, 2021)
2023: $182
| Baxter Healthcare | Hillrom - Carnation Ambulatory Monitor | $58 | 1 payment
|
| Novo Nordisk | Ozempic | $31 | 2 payments
|
| Kerecis | Kerecis Omega3 Surgiclose | $25 | 1 payment
|
| Kestra Medical Technology Services | Assure Wcd | $22 | 1 payment
|
| E.R. Squibb & Sons L.L.C. | Camzyos | $16 | 1 payment
|
| Abbott Laboratories | Mitraclip | $15 | 1 payment
|
| Impulse Dynamics (USA) | Optimizer | $15 | 1 payment
|
2022: $676
| Philips Electronics North America | (8874) Incourage | $430 | 12 payments
|
| Novo Nordisk | Rybelsus | $73 | 5 payments
|
| Abbott Laboratories | Thoratec Heartmate 3 Lvas Implant Kit | $53 | 3 payments
|
| Janssen Pharmaceuticals | Xarelto | $50 | 3 payments
|
| E.R. Squibb & Sons L.L.C. | Eliquis | $30 | 2 payments
|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Lifevest | $23 | 1 payment
|
| AngioDynamics | Duramax | $19 | 1 payment
|
2021: $561
| Janssen Pharmaceuticals | Xarelto | $216 | 19 payments
|
| Abbott Laboratories | Heartmate 3 Left Ventricular Assist Device | $77 | 5 payments
|
| Amgen | Repatha | $64 | 4 payments
|
| Astellas Pharma US | Lexiscan | $40 | 2 payments
|
| Sanofi-Aventis U.S. | Multaq | $37 | 2 payments
|
| Actelion Pharmaceuticals US | Opsumit | $29 | 2 payments
|
| Merck Sharp & Dohme | Verquvo | $16 | 1 payment
|
| AstraZeneca Pharmaceuticals LP | Brilinta | $16 | 1 payment
|
| Amarin Pharma | Vascepa | $15 | 1 payment
|
| Novo Nordisk | Rybelsus | $14 | 1 payment
|
| E.R. Squibb & Sons L.L.C. | Eliquis | $14 | 1 payment
|
| Esperion Therapeutics | Nexletol | $13 | 1 payment
|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Lifevest | $10 | 1 payment
|
Checkups this office reported
9 measures · 2023
Medicare asked this office to report how often certain checkups happened in 2023. This is not a grade for the doctor. A specialist’s patients may not need every screening.
- Medicare’s overall office score
- 75.6 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
| Asked about smokingPatients asked about tobacco, with help to quit if they smoke | 69%That's more than half. | 1,262 |
| Blood pressure under controlPeople with high blood pressure whose reading was in a healthy range | 73%That's more than half. | 1,139 |
| Closing the Referral Loop: Receipt of Specialist ReportAs Medicare defines this measure | 45% | 51 |
| Coronary Artery Disease (CAD): Beta-Blocker Therapy Prior Myocardial Infarction (MI) or Left Ventricular Systolic Dysfunction (LVEF <= 40%)As Medicare defines this measure | 83% | 36 |
| Medications listed in the chartVisits where the current medication list was documented | 99%That's most of the people this applied to. | 2,278 |
| Patients can see their records onlinePatients who were given electronic access to their health information | 69%That's more than half. | 982 |
| Prescriptions sent electronicallyPrescriptions sent to the pharmacy by computer instead of paper | 95%That's most of the people this applied to. | 130 |
| Risky medications in older adultsOlder patients given a medication that is risky at their age | 0%That's few of the people this applied to. Better on this measure. | 1,242 |
See the other 1 measures
| Screening for High Blood Pressure and Follow-Up DocumentedAs Medicare defines this measure | 28% | 703 |
What the office says it does
Boxes the office ticked on its Medicare worksheet for 2023. Nobody checks these.
- Agreed to federal review of their records system
- Checks the state prescription-drug database before prescribing
- Did a security review of patient data
- Exchanges records both ways with other health systems
- High Priority Practices Guide of the Safety Assurance Factors for EHR Resilience (SAFER) Guides
- Implementation of fall screening and assessment programs
- Implementation of medication management practice improvements
- Improved the patient portal
- Lets patients read their visit notes
- ONC-ACB Surveillance Attestation
- Reports cases to public health electronically
- Reports to a public-health or clinical registry
- Tobacco use
- Uses standard treatment protocols
- Exempt from immunization registry reporting
Professional record
- NPI
- 1992797799
- Licence
- OK 2557
- Video visits
- Lists video visits
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Physician assistant (363A00000X)
- Mailing address
- 3200 Quail Springs Pkwy, Suite 200, Oklahoma City, OK, 73134
- NPI first listed
- 2005-08-17
- NPI last updated
- 2016-10-04
This is when the NPI record was last certified, not a medical board exam.